A new way to pack gene-blocking RNA into tiny particles from milk
Original title: Development of Small Interfering RNA-Loaded Extracellular Vesicles via a High-Pressure Homogenization Approach.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done with cells in a dish in a lab.
The short version
This was a lab test of a new way to carry a gene-blocking drug into brain tumor cells grown in a dish.
What was studied. Researchers worked with tiny bubble-like particles, called extracellular vesicles, taken from cow's milk. They used a high pressure method to pack a gene-blocking molecule called siRNA into those particles, and they added a tag meant to stick to tumor cells.
What they found. The high pressure method did load the siRNA onto the milk particles. The tagged particles stuck strongly to a human glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary cell line in the lab and delivered the siRNA inside the cells. The tagged particles turned down the target gene better than the untagged particles did. The abstract does not give any numbers.
What this means, and what it doesn't
What it could mean: It is a step toward building a delivery system that could be made in larger amounts. The authors say this is the first time this method has been shown to work with siRNA. For a patient today, it changes nothing about care.
What it doesn't mean: This is not a treatment. It was done in the lab, with cells in a dish, not in people and not in animals. It does not show that anyone lived longer or felt better. It is not a cure, and there is no way to ask a doctor for it. Work like this takes many more years and many more steps before it could ever be tested in people.
Source: PubMed, August 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.